Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

Clinical trial NCT05136898 · COMPLETED

Trial details

NCT number: NCT05136898
Sponsor: UroGen Pharma Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bladder Cancer Urothelial Carcinoma Urothelial Carcinoma Bladder

Start date: 2021-11-30
Primary completion: 2023-02-02
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.